Shuttle Pharmaceuticals Holdings Inc (SHPH) FinancialsSHPHShuttle Pharmaceuticals Holdings Inc

Evaluating the bottom line, Shuttle Pharmaceuticals Holdings Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -90.05%, provide a clear picture of how effectively SHPH converts its operational activities into shareholder value.

In the context of the broader market, SHPH competes directly with industry leaders such as BYSI and ABVC. With a market capitalization of $24.94M, it holds a significant position in the sector. When comparing efficiency, SHPH's gross margin of N/A stands against BYSI's N/A and ABVC's N/A. Such benchmarking helps identify whether Shuttle Pharmaceuticals Holdings Inc is trading at a premium or discount relative to its financial performance.

SHPH has reported negative earnings per share (EPS) with a current EPS of -3.84, and a forward P/E ratio of 0, indicating no earnings expected in the near term. The company has been experiencing significant losses, with net income losses ranging from approximately -1.5 million to -3.4 million USD in recent quarters.